Stocks and Investing Stocks and Investing
Fri, March 24, 2023
Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023

Edward Nash Maintained (AKRO) at Strong Buy with Increased Target to $58 on, Mar 21st, 2023


Published on 2024-10-28 02:21:09 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $50 to $58 on, Mar 21st, 2023.

Edward has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Edward's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Edward


  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $64 on, Monday, March 20th, 2023
  • Michael Ulz of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $65 on, Friday, January 27th, 2023